Today in News History
On July 12, several notable moments in the history of News stand out. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1913, Willis Lamb, American physicist and academic, Nobel Prize laureate (died 2008) was born. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1948, Richard Simmons, American fitness trainer and actor (died 2024) was born. In 1997, Malala Yousafzai, Pakistani-English activist, Nobel Prize laureate was born. In 2000, Charles Merritt, Canadian colonel and politician, Victoria Cross recipient (born 1908) passed away. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. In 2006, The 2006 Lebanon War begins. In 2012, Syrian Civil War: Government forces target the homes of rebels and activists in Tremseh and kill anywhere between 68 and 150 people. Together, these milestones provide historical context for today's news news and ongoing narratives.
Autoimmune Relief, Gut Testing, Work in the Future | THRR208
Please Subscribe and Review: Apple Podcasts | RSS Submit your questions for the podcast here News Topic: Tylenol and autism: https://www.youtube.com/shorts/YLD5ywh-WM0 https://x.com/WallStreetApes/status/1971019653624496521 Show Notes: X post by Andrew Zywiec MD DNA analysis with Dr. Anthony Jay Article from Smart Cities Dive: Life as a Lunatic: Polyface Farms’ Joel Salatin Mark Moss: The Wealth Boom Continue Reading
Narrative Intelligence Brief
This article was published by Robb Wolf, a source frequently categorized with a right bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Robb Wolf, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Robb Wolf
September 19, 2025
Fueling BJJ, Lifting for Health, Post Heart Attack Plan | THRR207
March 8, 2025
Mast Cell Activation Syndrome, Dry Fasting | THRR205
April 6, 2025
Hernia Repair, Optimal Dietary Patterns for Healthy Aging | THRR206
February 22, 2025
Stomach Issues, Meat and Eczema | THRR204
January 31, 2025
High Iron Levels, Optimal Glucose Level, Lead Testing | THRR203
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinal"
Former Spanish PM Mariano Rajoy makes racist remarks about France's football team
[Photo] JUST IN: 🇦🇷 Argentina officially advances to the FIFA World Cup semifinal after defeat [...]
Argentina's hero: "We are just two steps away from the goal"
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 33%
Center 33%
Right 33%
The Eastern Herald
· Jul 5, 2026
FDA Clears a Transplant Therapy Built to Cut Chronic GVHD From 44% to 13%
The FDA approved Tregzi, Orca Bio's engineered cell therapy, after a 187-patient trial found it cut moderate-to-severe chronic graft-versus-host disease from 44 with standard transplants to 13. The tradeoff patients now face is a newer therapy without years of follow-up data behind it.
Seeking Alpha
· Jul 7, 2026
Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b Transcript
Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b Transcript
Jezebel
· Jun 25, 2026
The Pentagon Lost Its War Against Flu Shots in Less than Two Months
Flu shots are mandatory once again, less than two months after being made optional, following a major military base outbreak.
Investing.com
· Jun 30, 2026
Form 144 Immunome For: 30 June
Form 144 Immunome For: 30 June
NaturalNews.com
· Jul 4, 2026
Some IBD Patients Produce Antibodies That Block Key Inflammation Regulator, Study Finds
(NaturalNews) Study Finds Autoantibodies Against IL-10 in Subset of IBD PatientsApproximately 3.5 percent of people with inflammatory bowel disease (IBD) produce ...
Bloomberg
· Jun 25, 2026
Moderna CEO: Cautiously Optimistic on Flu Vaccine Approval
The FDA advisory committee recommended Moderna's flu vaccine for approval. Moderna CEO Stéphane Bancel tells Romaine Bostick and Katie Greifeld he is cautiously optimistic the approval will happen. (Source: Bloomberg)
Topics:
Related coverage for "Autoimmune Relief, Gut Testing, Work in the Future | THRR208": The Eastern Herald — FDA Clears a Transplant Therapy Built to Cut Chronic GVHD From 44% to 13%. Seeking Alpha — Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b Transcript. Jezebel — The Pentagon Lost Its War Against Flu Shots in Less than Two Months. Investing.com — Form 144 Immunome For: 30 June. NaturalNews.com — Some IBD Patients Produce Antibodies That Block Key Inflammation Regulator, Study Finds. Bloomberg — Moderna CEO: Cautiously Optimistic on Flu Vaccine Approval